2023-2029 Global Exosome Proteomics Service Industry Research & Trends Analysis Report
Report Code: KNJ1619128 No. of Pages: 167 Category: Services
Publisher: Date of Publish:
Publisher: Date of Publish:
According to YH Research, the global market for Exosome Proteomics Service should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Exosome Proteomics Service market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Exosome Proteomics Service market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Separate segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Biomarker Discovery has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Exosome Proteomics Service include System Biosciences, HansaBioMed Life Sciences Ltd., QIAGEN Inc., Norgen Biotek Corp., Bio-Techne, AMSBIO LLC, NX Pharmagen, Thermo Fisher Scientific and Sistemic Ltd., etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Exosome Proteomics Service. Report Highlights:
(1) Global Exosome Proteomics Service market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Exosome Proteomics Service market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Exosome Proteomics Service market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Exosome Proteomics Service segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Exosome Proteomics Service segment by type and by application and regional segment by type and by application.
(6) Exosome Proteomics Service industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Separate
Identification and Characterization
Quantitative Analysis
Content Analysis
Functional Analysis
Market segment by application, can be divided into
Biomarker Discovery
Drug Delivery
Disease Diagnosis and Monitoring
Personalized Medicine
Others
Market segment by players, this report covers
System Biosciences
HansaBioMed Life Sciences Ltd.
QIAGEN Inc.
Norgen Biotek Corp.
Bio-Techne
AMSBIO LLC
NX Pharmagen
Thermo Fisher Scientific
Sistemic Ltd.
Exosome Diagnostics
Lonza Group Ltd.
Evox Therapeutics Ltd.
Evomic Science LLC
ExoCyte Therapeutics LLC
Optofluidics, Inc.
New England Biolabs
Izon Science Ltd.
Miltenyi Biotec GmbH
Codiak BioSciences
Ology Bioservices Inc.
1 Market Overview
1.1 Product Overview and Scope of Exosome Proteomics Service
1.2 Global Exosome Proteomics Service Market Size and Forecast
1.3 China Exosome Proteomics Service Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Exosome Proteomics Service Share in Global Market, 2018-2029
1.4.2 Exosome Proteomics Service Market Size: China VS Global, 2018-2029
1.5 Exosome Proteomics Service Market Dynamics
1.5.1 Exosome Proteomics Service Market Drivers
1.5.2 Exosome Proteomics Service Market Restraints
1.5.3 Exosome Proteomics Service Industry Trends
1.5.4 Exosome Proteomics Service Industry Policy
2 Global Competitive Situation by Company
2.1 Global Exosome Proteomics Service Revenue by Company (2018-2023)
2.2 Global Exosome Proteomics Service Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Exosome Proteomics Service Concentration Ratio
2.4 Global Exosome Proteomics Service Mergers & Acquisitions, Expansion Plans
2.5 Global Exosome Proteomics Service Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Exosome Proteomics Service Revenue by Company (2018-2023)
3.2 China Exosome Proteomics Service Exosome Proteomics Service Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Exosome Proteomics Service, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Exosome Proteomics Service Industry Chain
4.2 Exosome Proteomics Service Upstream Analysis
4.3 Exosome Proteomics Service Midstream Analysis
4.4 Exosome Proteomics Service Downstream Analysis
5 Sights by Type
5.1 Exosome Proteomics Service Classification
5.1.1 Separate
5.1.2 Identification and Characterization
5.1.3 Quantitative Analysis
5.1.4 Content Analysis
5.1.5 Functional Analysis
5.2 By Type, Global Exosome Proteomics Service Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Exosome Proteomics Service Revenue, 2018-2029
6 Sights by Application
6.1 Exosome Proteomics Service Segment by Application
6.1.1 Biomarker Discovery
6.1.2 Drug Delivery
6.1.3 Disease Diagnosis and Monitoring
6.1.4 Personalized Medicine
6.1.5 Others
6.2 By Application, Global Exosome Proteomics Service Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Exosome Proteomics Service Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Exosome Proteomics Service Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Exosome Proteomics Service Market Size, 2018-2029
7.3 North America
7.3.1 North America Exosome Proteomics Service Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Exosome Proteomics Service Market Size Market Share
7.4 Europe
7.4.1 Europe Exosome Proteomics Service Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Exosome Proteomics Service Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Exosome Proteomics Service Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Exosome Proteomics Service Market Size Market Share
7.6 South America
7.6.1 South America Exosome Proteomics Service Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Exosome Proteomics Service Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Exosome Proteomics Service Market Size & CAGR，2018 VS 2022 VS 2029
8.2 By Country, Global Exosome Proteomics Service Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Exosome Proteomics Service Market Size, 2018-2029
8.3.2 By Company, U.S. Exosome Proteomics Service Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Exosome Proteomics Service Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Exosome Proteomics Service Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Exosome Proteomics Service Market Size, 2018-2029
8.4.2 By Company, Europe Exosome Proteomics Service Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Exosome Proteomics Service Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Exosome Proteomics Service Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Exosome Proteomics Service Market Size, 2018-2029
8.5.2 By Company, China Exosome Proteomics Service Revenue Market Share, 2018-2023
8.5.3 By Type, China Exosome Proteomics Service Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Exosome Proteomics Service Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Exosome Proteomics Service Market Size, 2018-2029
8.6.2 By Company, Japan Exosome Proteomics Service Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Exosome Proteomics Service Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Exosome Proteomics Service Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Exosome Proteomics Service Market Size, 2018-2029
8.7.2 By Company, South Korea Exosome Proteomics Service Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Exosome Proteomics Service Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Exosome Proteomics Service Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Exosome Proteomics Service Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Exosome Proteomics Service Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Exosome Proteomics Service Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Exosome Proteomics Service Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Exosome Proteomics Service Market Size, 2018-2029
8.9.2 By Company, India Exosome Proteomics Service Revenue Market Share, 2018-2023
8.9.3 By Type, India Exosome Proteomics Service Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Exosome Proteomics Service Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Exosome Proteomics Service Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Exosome Proteomics Service Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Exosome Proteomics Service Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Exosome Proteomics Service Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 System Biosciences
9.1.1 System Biosciences Company Information, Head Office, Market Area and Industry Position
9.1.2 System Biosciences Company Profile and Main Business
9.1.3 System Biosciences Exosome Proteomics Service Models, Specifications and Application
9.1.4 System Biosciences Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.1.5 System Biosciences Recent Developments
9.2 HansaBioMed Life Sciences Ltd.
9.2.1 HansaBioMed Life Sciences Ltd. Company Information, Head Office, Market Area and Industry Position
9.2.2 HansaBioMed Life Sciences Ltd. Company Profile and Main Business
9.2.3 HansaBioMed Life Sciences Ltd. Exosome Proteomics Service Models, Specifications and Application
9.2.4 HansaBioMed Life Sciences Ltd. Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.2.5 HansaBioMed Life Sciences Ltd. Recent Developments
9.3 QIAGEN Inc.
9.3.1 QIAGEN Inc. Company Information, Head Office, Market Area and Industry Position
9.3.2 QIAGEN Inc. Company Profile and Main Business
9.3.3 QIAGEN Inc. Exosome Proteomics Service Models, Specifications and Application
9.3.4 QIAGEN Inc. Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.3.5 QIAGEN Inc. Recent Developments
9.4 Norgen Biotek Corp.
9.4.1 Norgen Biotek Corp. Company Information, Head Office, Market Area and Industry Position
9.4.2 Norgen Biotek Corp. Company Profile and Main Business
9.4.3 Norgen Biotek Corp. Exosome Proteomics Service Models, Specifications and Application
9.4.4 Norgen Biotek Corp. Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.4.5 Norgen Biotek Corp. Recent Developments
9.5 Bio-Techne
9.5.1 Bio-Techne Company Information, Head Office, Market Area and Industry Position
9.5.2 Bio-Techne Company Profile and Main Business
9.5.3 Bio-Techne Exosome Proteomics Service Models, Specifications and Application
9.5.4 Bio-Techne Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.5.5 Bio-Techne Recent Developments
9.6 AMSBIO LLC
9.6.1 AMSBIO LLC Company Information, Head Office, Market Area and Industry Position
9.6.2 AMSBIO LLC Company Profile and Main Business
9.6.3 AMSBIO LLC Exosome Proteomics Service Models, Specifications and Application
9.6.4 AMSBIO LLC Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.6.5 AMSBIO LLC Recent Developments
9.7 NX Pharmagen
9.7.1 NX Pharmagen Company Information, Head Office, Market Area and Industry Position
9.7.2 NX Pharmagen Company Profile and Main Business
9.7.3 NX Pharmagen Exosome Proteomics Service Models, Specifications and Application
9.7.4 NX Pharmagen Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.7.5 NX Pharmagen Recent Developments
9.8 Thermo Fisher Scientific
9.8.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
9.8.2 Thermo Fisher Scientific Company Profile and Main Business
9.8.3 Thermo Fisher Scientific Exosome Proteomics Service Models, Specifications and Application
9.8.4 Thermo Fisher Scientific Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.8.5 Thermo Fisher Scientific Recent Developments
9.9 Sistemic Ltd.
9.9.1 Sistemic Ltd. Company Information, Head Office, Market Area and Industry Position
9.9.2 Sistemic Ltd. Company Profile and Main Business
9.9.3 Sistemic Ltd. Exosome Proteomics Service Models, Specifications and Application
9.9.4 Sistemic Ltd. Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.9.5 Sistemic Ltd. Recent Developments
9.10 Exosome Diagnostics
9.10.1 Exosome Diagnostics Company Information, Head Office, Market Area and Industry Position
9.10.2 Exosome Diagnostics Company Profile and Main Business
9.10.3 Exosome Diagnostics Exosome Proteomics Service Models, Specifications and Application
9.10.4 Exosome Diagnostics Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.10.5 Exosome Diagnostics Recent Developments
9.11 Lonza Group Ltd.
9.11.1 Lonza Group Ltd. Company Information, Head Office, Market Area and Industry Position
9.11.2 Lonza Group Ltd. Company Profile and Main Business
9.11.3 Lonza Group Ltd. Exosome Proteomics Service Models, Specifications and Application
9.11.4 Lonza Group Ltd. Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.11.5 Lonza Group Ltd. Recent Developments
9.12 Evox Therapeutics Ltd.
9.12.1 Evox Therapeutics Ltd. Company Information, Head Office, Market Area and Industry Position
9.12.2 Evox Therapeutics Ltd. Company Profile and Main Business
9.12.3 Evox Therapeutics Ltd. Exosome Proteomics Service Models, Specifications and Application
9.12.4 Evox Therapeutics Ltd. Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.12.5 Evox Therapeutics Ltd. Recent Developments
9.13 Evomic Science LLC
9.13.1 Evomic Science LLC Company Information, Head Office, Market Area and Industry Position
9.13.2 Evomic Science LLC Company Profile and Main Business
9.13.3 Evomic Science LLC Exosome Proteomics Service Models, Specifications and Application
9.13.4 Evomic Science LLC Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.13.5 Evomic Science LLC Recent Developments
9.14 ExoCyte Therapeutics LLC
9.14.1 ExoCyte Therapeutics LLC Company Information, Head Office, Market Area and Industry Position
9.14.2 ExoCyte Therapeutics LLC Company Profile and Main Business
9.14.3 ExoCyte Therapeutics LLC Exosome Proteomics Service Models, Specifications and Application
9.14.4 ExoCyte Therapeutics LLC Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.14.5 ExoCyte Therapeutics LLC Recent Developments
9.15 Optofluidics, Inc.
9.15.1 Optofluidics, Inc. Company Information, Head Office, Market Area and Industry Position
9.15.2 Optofluidics, Inc. Company Profile and Main Business
9.15.3 Optofluidics, Inc. Exosome Proteomics Service Models, Specifications and Application
9.15.4 Optofluidics, Inc. Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.15.5 Optofluidics, Inc. Recent Developments
9.16 New England Biolabs
9.16.1 New England Biolabs Company Information, Head Office, Market Area and Industry Position
9.16.2 New England Biolabs Company Profile and Main Business
9.16.3 New England Biolabs Exosome Proteomics Service Models, Specifications and Application
9.16.4 New England Biolabs Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.16.5 New England Biolabs Recent Developments
9.17 Izon Science Ltd.
9.17.1 Izon Science Ltd. Company Information, Head Office, Market Area and Industry Position
9.17.2 Izon Science Ltd. Company Profile and Main Business
9.17.3 Izon Science Ltd. Exosome Proteomics Service Models, Specifications and Application
9.17.4 Izon Science Ltd. Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.17.5 Izon Science Ltd. Recent Developments
9.18 Miltenyi Biotec GmbH
9.18.1 Miltenyi Biotec GmbH Company Information, Head Office, Market Area and Industry Position
9.18.2 Miltenyi Biotec GmbH Company Profile and Main Business
9.18.3 Miltenyi Biotec GmbH Exosome Proteomics Service Models, Specifications and Application
9.18.4 Miltenyi Biotec GmbH Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.18.5 Miltenyi Biotec GmbH Recent Developments
9.19 Codiak BioSciences
9.19.1 Codiak BioSciences Company Information, Head Office, Market Area and Industry Position
9.19.2 Codiak BioSciences Company Profile and Main Business
9.19.3 Codiak BioSciences Exosome Proteomics Service Models, Specifications and Application
9.19.4 Codiak BioSciences Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.19.5 Codiak BioSciences Recent Developments
9.20 Ology Bioservices Inc.
9.20.1 Ology Bioservices Inc. Company Information, Head Office, Market Area and Industry Position
9.20.2 Ology Bioservices Inc. Company Profile and Main Business
9.20.3 Ology Bioservices Inc. Exosome Proteomics Service Models, Specifications and Application
9.20.4 Ology Bioservices Inc. Exosome Proteomics Service Revenue and Gross Margin, 2018-2023
9.20.5 Ology Bioservices Inc. Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com